Shareholder Info

Capital Structure

As of April 12, 2021, the company has 14,467,380 issued shares with a nominal value of NIS 0.01 each (Corresponding to 14,467,380 voting rights)

Ownership structure

As of April 12, 2021, SHL was aware of the following shareholders with more than 3% of all voting rights in the company.

  Number % Including Treasury Shares % Excluding Treasury Shares
Cai Mengke and Shen Kun
5,969,413
41.26%
41.44%
Alroy Group 2,507,608
17.33%
17.41%
More Provident Funds 894,332
6.18%
6.21%
Value Base Group 837,865
5.79%
5.82%
Sphera Funds Management Ltd. 596,000
4.12%
4.14%
Danbar Finance Ltd.
540,000
3.73%
3.75%
Treasury shares 64,037
0.44%
Public
3,058,125
21.15%
21.23%

The above table of Significant Shareholders reflects both actual holdings as of April 12, 2021, after deducting from the total number of shares outstanding 64,037 Ordinary Shares held by SHL, and actual holdings as of April 12, 2021 calculated including ordinary shares held by SHL, all as indicated above, but does not reflect holdings on a fully diluted basis. All in accordance with notifications received by the Company from its shareholders as of April 12, 2021.

Disclosure of Management Transactions
SHL Telemedicine has to report to SIX Swiss Exchange all transactions of SHL shares and options made by the Board of Directors and the executive management.The disclosure of management transactions is intended as a means of furthering the supply of information to investors. Such disclosure provides investors with additional qualitative insight with regard to their investment decision.
Click here for the Management Transaction disclosure of SHL Telemedicine on the SIX-Platform.